Vitamin D uptake in chronic kidney disease
- Conditions
- N18Chronic kidney disease
- Registration Number
- DRKS00029157
- Lead Sponsor
- niversitätsklinikum der RWTH Aachen
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 20
• stable, chronic hemodialysis patients
• Age of = 18 years
• Written informed consent prior to study participation
• The subject is willing and able to follow the procedures outlined in the protocol
Control group:
• Normal renal function
• Age- and sex-matched as well as written informed consent prior to study participation
• The subject is willing and able to follow the procedures outlined in the protocol
• Age less than 18 years
• Severe medical events within the last month
• Planned surgery within the duration of the sampling
• Acute/chronic gastrointestinal infections
• Recent or ongoing antibiotic therapy
• Conditions that impair vitamin D uptake or metabolism (chronic inflammatory bowel disease)
• Severe dyslipidemia
• Severe anemia, defined as hemoglobin level less than 9.0 g/dl
• Pregnant and lactating females
• Committed to an institution by legal or regulatory order
• Participation in a parallel interventional clinical trial
• Receipt of an investigational drug within 30 days prior to inclusion into this study
• The subject is mentally or legally incapacitated
• Vitamin D supplementation
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Determination of vitamin D content in lipoproteins up to 96h after ingestion
- Secondary Outcome Measures
Name Time Method